Beacon Pointe Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$614K Buy
6,788
+605
+10% +$55.5K ﹤0.01% 1206
2025
Q4
$556K Sell
6,183
-96
-2% -$9.1K ﹤0.01% 1044
2025
Q3
$618K Sell
6,279
-1,748
-22% -$173K 0.01% 939
2025
Q2
$732K Sell
8,027
-675
-8% -$65.3K 0.01% 770
2025
Q1
$985K Buy
8,702
+618
+8% +$66.1K 0.01% 642
2024
Q4
$854K Sell
8,084
-447
-5% -$48K 0.01% 684
2024
Q3
$921K Buy
8,531
+349
+4% +$38.1K 0.01% 653
2024
Q2
$888K Sell
8,182
-279
-3% -$32.9K 0.01% 677
2024
Q1
$1.12M Sell
8,461
-1,306
-13% -$163K 0.01% 656
2023
Q4
$1.19M Sell
9,767
-310
-3% -$34.6K 0.01% 617
2023
Q3
$1.13M Buy
10,077
+1,959
+24% +$249K 0.01% 596
2023
Q2
$1.18M Sell
8,118
-961
-11% -$131K 0.02% 490
2023
Q1
$1.17M Buy
9,079
+1,259
+16% +$158K 0.02% 501
2022
Q4
$997K Sell
7,820
-1,920
-20% -$223K 0.02% 504
2022
Q3
$1.02M Buy
9,740
+1,694
+21% +$186K 0.02% 458
2022
Q2
$845K Sell
8,046
-40
-0.5% -$4.75K 0.02% 511
2022
Q1
$1.03M Buy
8,086
+3,840
+90% +$463K 0.01% 608
2021
Q4
$524K Sell
4,246
-3,121
-42% -$408K 0.01% 559
2021
Q3
$1.05M Buy
7,367
+5,099
+225% +$750K 0.03% 399
2021
Q2
$354K Buy
+2,268
New +$367K 0.01% 608

Other funds holding ZBH

Beacon Pointe Advisors's ZBH Position: Q1 2026 in Review

Beacon Pointe Advisors increased its Zimmer Biomet (ZBH) stake by 9.8% in Q1 2026, buying an estimated $55.5K and bringing the position to 6,788 shares worth $614K. The position accounts for ﹤0.01% of the portfolio, ranked #1206.

Beacon Pointe Advisors first reported a position in ZBH in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.19M in Q4 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Beacon Pointe Advisors held 6,788 shares of Zimmer Biomet worth $614K as of Q1 2026.
  • Beacon Pointe Advisors bought 605 Zimmer Biomet shares in Q1 2026, an estimated $55.5K.
  • Zimmer Biomet made up ﹤0.01% of Beacon Pointe Advisors's portfolio in Q1 2026, its #1206 holding.
  • Beacon Pointe Advisors first reported a position in Zimmer Biomet in Q2 2021 and has held it in 20 quarters since.
  • Beacon Pointe Advisors's Zimmer Biomet position peaked at $1.19M in Q4 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Beacon Pointe Advisors's 13F filing for Q1 2026, filed 15 May 2026.